JiscMail Logo
Email discussion lists for the UK Education and Research communities

Help for GP-UK Archives


GP-UK Archives

GP-UK Archives


GP-UK@JISCMAIL.AC.UK


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

GP-UK Home

GP-UK Home

GP-UK  March 2008

GP-UK March 2008

Options

Subscribe or Unsubscribe

Subscribe or Unsubscribe

Log In

Log In

Get Password

Get Password

Subject:

Re: Prozac et al

From:

Fay Wilson <[log in to unmask]>

Reply-To:

GP-UK <[log in to unmask]>

Date:

Sun, 2 Mar 2008 17:28:53 +0000

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (110 lines)

I'm not convinced that we should accept that GPs throw these around for 
transient low mood or emotional upsets.

If they are as effective as placebos (which we are not ethically 
permitted to use) that is worth having and maybe we should look at them 
more positively, as well as being grateful that they will also cover the 
odd case of severe depression that we thought was "not so bad" and 
without treatment may go on to self harm. It seems not time at all since 
we were beset by headlines about the number of people who had committed 
suicide within a month of seeing their GPs who had failed to recognise 
their depression or take it seriously.

I wonder whether it is justifiable to spend the huge sums of money that 
would be required for universal CBT for everyone with transient low mood 
/ emotional upset?
Fay

Paul Caldwell wrote:
> i think the point about the SSRI debate is that there is little 
> evidence that they are useful for mild depression let alone the low 
> mood/emotional upsets that we GPs frequently use them for almost as a 
> reflex. the large majority of these pts will get better in time 
> whatever one does and little interventions make a difference overall 
> to that natural history. pts are more at risk of the medication than 
> the disease. importantly prescribing ADs sends powerful messages to 
> pts not dissimilar to ABs for minor infection. 'Talking treatments' 
> are useful for these pts as they appear to give greater solace to 
> unhappy people than medication. just as importantly an essential part 
> of talking treatments is getting pts to be active about doing 
> something for themselves, gaining perspective+self esteem, and 
> crucially how to deal with it and recognise it the next time they get 
> depression (which is recurrent within 5 years in most). I freely admit 
> that profioundly unhappy pts want a quick fix for obvious reasons, as 
> did I. i'm happy to prescribe placebos as long as it is clear to pts 
> that they are so, i dont like lying to my pts! or being lied to. but 
> usually go down the route of talking therapies.
> Placebos. now there is a seriously interesting subject. any URL of 
> review on it?
> PS. granted the situation for talking therapies, will we get into the 
> era of ADs for the working classes and CBT for the middle class who 
> pay for it?
>
> > Date: Sat, 1 Mar 2008 11:13:43 +0000
> > From: [log in to unmask]
> > Subject: Re: Prozac et al
> > To: [log in to unmask]
> >
> > At 14:30 28/02/2008, you wrote:
> > >On Thu, Feb 28, 2008 at 9:30 AM, Paul Caldwell <[log in to unmask]> wrote:
> > > >
> > > > agreed. often used in 2 ways-like antibiotics "give me something
> > > to make me
> > > > well now" or as placebo for docs who do not have access to CMHTs 
> etc.
> > > > interestingly, the data is not knew and i am surprised that
> > > unpublished data
> > > > was allowed to remain so for so long. perhaps ben goldacre has a
> > > point: that
> > > > publsihing trials should be compulsory and not discretionary on the
> > > > trialist.
> > > >
> > > >
> > >
> > >There is a simple solution to this that all the regulatory agencies
> > >have declined to implement: only pre-registered trials should be
> > >admissible when applying for a licence. All trials would therefore
> > >have to be registered before starting (in case they produced good
> > >results), so the licensing agencies could immediately see what
> > >proportion of the total trials had produced positive results.
> > >
> > >Cheers Geoff
> >
> > I thought that's exactly what the FDA had done?
> >
> > Publication bias still remains, and who wants to publish a study that
> > an unheard of chemical entity doesn't work?
> >
> > That only becomes newsworthy AFTER a drug is in widespread use.
> >
> > OTOH the meta-analysis is probably not reliable either and is not
> > relevant to UK general practice where the treatment options are
> > different to those available in the studies.
> >
> > This is a long running saga. It's also deeply rooted in human
> > behaviour. The dangers of resorting to nicotine in times of stress,
> > the habit of "getting plastered" when life is hard seem to me to be
> > far more dangerous than the prescriptions that GPs
> > issue for anti-depressants, only some of which are ever used. In GP
> > land these do represent BOTH useful treatments for many patients, and
> > tokens of care with acceptance of the degree of human suffering - a
> > stark alternative to the minimalist "pull yourself together" approach
> > (though taking responsibility for self is of course the end point we
> > all aim for).
> >
> > In any case happy to work with patients own decisions, so long as
> > they don't ask me for something that doesn't exist / isn't accessible.
> >
> > Julian
>
>
> ------------------------------------------------------------------------
> Play Live Search Charades and win £5000 Think you know your TV, music 
> and film? <http://www.searchcharades.com>
> ------------------------------------------------------------------------
>
> No virus found in this incoming message.
> Checked by AVG Free Edition. 
> Version: 7.5.516 / Virus Database: 269.21.3/1306 - Release Date: 01/03/2008 17:41
>   

Top of Message | Previous Page | Permalink

JiscMail Tools


RSS Feeds and Sharing


Advanced Options


Archives

March 2024
October 2023
August 2023
June 2023
May 2023
February 2023
June 2022
October 2021
January 2021
October 2020
September 2020
August 2020
July 2020
June 2020
March 2020
January 2020
December 2019
September 2019
July 2019
June 2019
May 2019
March 2019
February 2019
January 2019
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
March 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996


JiscMail is a Jisc service.

View our service policies at https://www.jiscmail.ac.uk/policyandsecurity/ and Jisc's privacy policy at https://www.jisc.ac.uk/website/privacy-notice

For help and support help@jisc.ac.uk

Secured by F-Secure Anti-Virus CataList Email List Search Powered by the LISTSERV Email List Manager